State Board of Administration of Florida Retirement System
KALV

State Board of Administration of Florida Retirement System’s KalVista Pharmaceuticals KALV Stock Holding History

State Board of Administration of Florida Retirement System’s Portfolio KALV Stock Details KALV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-9,695
Closed -$232K – 2408
2021
Q2 		$232K Buy
+9,695
New +$254K ﹤0.01% 2233

Other funds holding KALV

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

State Board of Administration of Florida Retirement System's KALV Position: Q3 2021 in Review

State Board of Administration of Florida Retirement System sold out of KalVista Pharmaceuticals (KALV) in Q3 2021, closing a stake of 9,695 shares — an estimated $232K sold.

State Board of Administration of Florida Retirement System first reported a position in KALV in Q2 2021 and held it in 1 quarter. The position peaked at $232K in Q2 2021. 105 funds tracked by Wall St. Rank hold KALV as of Q3 2021.

  • State Board of Administration of Florida Retirement System reported no remaining KalVista Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 9,695 KalVista Pharmaceuticals shares in Q3 2021, an estimated $232K.
  • State Board of Administration of Florida Retirement System first reported a position in KalVista Pharmaceuticals in Q2 2021 and held it in 1 quarter.
  • State Board of Administration of Florida Retirement System's KalVista Pharmaceuticals position peaked at $232K in Q2 2021.
  • 105 funds tracked by Wall St. Rank held KalVista Pharmaceuticals as of Q3 2021.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q3 2021, filed 8 Nov 2021.